Omron

Omron Reports Q3 Revenue of $2.1B, Profit Reverses Loss

Omron has released its consolidated financial results for the third quarter of fiscal year 2026, prepared according to US standards. The report is available in PDF format, with a file size of 388.8KB. This announcement provides investors and stakeholders with an update on the company's financial performance during the specified period.

Omron Tests Honda Swappable Batteries for Energy Storage

Omron has initiated a demonstration test utilizing Honda's swappable batteries for a storage system. This collaboration explores the integration of electric vehicle battery technology into stationary energy storage solutions. The test aims to evaluate the feasibility and performance of using these batteries for power storage and supply.

Omron Healthcare Develops AI to Predict Blood Pressure Measurement Continuity

Omron Healthcare has developed an AI model capable of predicting the continuity of blood pressure measurements. This model is trained on approximately 300,000 sets of home blood pressure data. The innovation aims to improve patient adherence to regular blood pressure monitoring, which is crucial for managing hypertension.

OMRON Healthcare Sells Over 50 Million Nebulizers Worldwide

OMRON Healthcare has achieved a significant milestone by selling over 50 million nebulizers worldwide since 1978. This accomplishment highlights the company's long-standing commitment to alleviating the burden of respiratory diseases globally.